Telix Pharmaceuticals (TLX) Debt Ratio (2023 - 2025)

Telix Pharmaceuticals (TLX) has disclosed Debt Ratio for 3 consecutive years, with 0.35 as the latest value for Q4 2025.

  • Quarterly Debt Ratio fell 7.56% to 0.35 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.38 through Dec 2024, up 1565.86% year-over-year, with the annual reading at 0.35 for FY2025, 7.56% down from the prior year.
  • Debt Ratio for Q4 2025 was 0.35 at Telix Pharmaceuticals, down from 0.38 in the prior quarter.
  • The five-year high for Debt Ratio was 0.38 in Q4 2024, with the low at 0.02 in Q4 2023.
  • Average Debt Ratio over 3 years is 0.25, with a median of 0.35 recorded in 2025.
  • The sharpest move saw Debt Ratio soared 1565.86% in 2024, then fell 7.56% in 2025.
  • Over 3 years, Debt Ratio stood at 0.02 in 2023, then soared by 1565.86% to 0.38 in 2024, then fell by 7.56% to 0.35 in 2025.
  • According to Business Quant data, Debt Ratio over the past three periods came in at 0.35, 0.38, and 0.02 for Q4 2025, Q4 2024, and Q4 2023 respectively.